The overall aim of this feasibility trial is to assess the effectiveness of a wearable technology and an e-diabetes prevention programme delivered via a smartphone application, including motivational messaging, in reducing weight and increasing physical activity in people at risk of developing type 2 diabetes.
The study will examine whether a wearable technology, combined with biofeedback, motivational messaging and an e-diabetes prevention programme, is effective in reducing weight and increasing physical activity after 12 months. The intervention will consist of a wearable technology and a smartphone application made available for a 12 month period. 22 online multimedia sessions targeting diet, physical activity and mental resilience delivered via the smartphone application. Motivational messaging based on the diabetes prevention module content and biofeedback will be sent to participants via the application. The control group will receive the wearable technology and will have access to a smartphone application detailing their activity. Participants will be directed to the same educational material as is made available via the multimedia sessions, but will not receive motivational messages.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
200
Buddi wearable technology will record activity levels, participants will access activity data through smartphone application
Educational material accessed through smartphone application
Messages sent via smartphone application
Physical activity (average steps per day)
Average steps taken per day from 7 days wear measured using the Buddi wearable technology, which will be worn 24 hours per day for 7 days
Time frame: 7 days
Weight (kg)
Measured in light clothing, without shoes, on the a Class 3 Tanita SC240 weighing digital scale to 0.01 kg for weight
Time frame: At 12 month follow-up appointment
HbA1c (mmol/mol)
Time frame: At 12 month follow-up appointment
Height (cm)
Time frame: At 12 month follow-up appointment
BMI (kg/m^2)
Time frame: At 12 month follow-up appointment
Waist circumference (cm)
Time frame: At 12 month follow-up appointment
Hip circumference (cm)
Time frame: At 12 month follow-up appointment
Total cholesterol (mmol/L)
Time frame: At 12 month follow-up appointment
High density lipoprotein cholesterol (mmol/L)
Time frame: At 12 month follow-up appointment
Low density lipoprotein cholesterol (mmol/L)
Time frame: At 12 month follow-up appointment
Systolic blood pressure (mmHg)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: At 12 month follow-up appointment
Diastolic blood pressure (mmHg)
Time frame: At 12 month follow-up appointment
Sleep duration (average hours per night)
The Buddi wearable technology will be worn for 24 hours per day. Therefore, during sleeping hours participant activity will be measured and duration of sleep can be calculated. Participants will wear the Buddi device for 7 days, and the average number of hours sleep per night will be calculated.
Time frame: 7 days